We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

FSAD - Women’s Health Study

This study is currently closed to enrollment.

A Phase 2b, Multi-Center, Multiple-Dose, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy And Safety Of Sildenafil Cream, 3.6% In Premenopausal Patients With Female Sexual Arousal Disorder (FSAD)

woman in bed with covers

 

AGE: Premenopausal women, 21 +
GENDER: Female
TYPE: Interventional Treatment Study
CONDITION: Female Sexual Arousal Disorder
HEALTHY PARTICIPANTS: Yes
DEPARTMENT: Obstetrics & Gynecology
LOCATION: UH Cleveland Medical Center

Study Purpose

The purpose of this study is to find out if the investigational drug, topical Sildenafil Cream, 3.6%, increases genital arousal in women during sexual activity.